MedTrace Logo

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

NCT05871762 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3705

Last updated 2023-08-28

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Conditions

  • Rectal Neoplasms

Interventions

OTHER

Registry study, no specific intervention

Registry study, no specific intervention

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-04
Primary Completion
2027-05-17
Completion
2027-05-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871762 on ClinicalTrials.gov